Items where Author is "Anjidani, N."

Article

(2022) Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia (R)) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial. ARTHRITIS RESEARCH & THERAPY. ISSN 1478-6354 1478-6362 J9 - ARTHRITIS RES THER

(2021) Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study. Advances in Therapy. pp. 1290-1300. ISSN 0741-238X

(2021) A Phase IV Study of the Safety and Efficacy of CinnoPar (R) in Iranian Patients with Osteoporosis. Journal of Osteoporosis. ISSN 2090-8059

(2021) Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2021) Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study. CASPIAN JOURNAL OF INTERNAL MEDICINE. S491-S494. ISSN 2008-6164 2008-6172 J9 - CASP J INTERN MED

(2021) Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar. FRONTIERS IN NEUROLOGY. ISSN 1664-2295 J9 - FRONT NEUROL

(2020) Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical Trial. Clinical Therapeutics. pp. 848-859. ISSN 0149-2918

(2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology. ISSN 1567-5769